Assessment of Kidney Injury Molecule-1 in Acute Kidney Injury in the Neonatal Intensive Care Unit: A Study in Northeast Iran from 2019 to 2020

• Egile Nagusiak: Mahshid Mehrjerdian (Egilea), Faridreza Hanafee (Egilea), Mahsa Besharat (Egilea), Ehsan Alaee (Egilea), Saeid Amirkhanlou (Egilea)
• Formatua: Liburua
• Argitaratua: Mashhad University of Medical Sciences, 2023-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: Drugs cause approximately 20%-40% of acute kidney injuries (AKI). Amikacin (AMK) is one of the common medications used as empiric therapy for severe infections, such as sepsis in neonates. One of the newly recommended biomarkers in AKI is Kidney Injury Molecule-1 (KIM-1). In this study,...